# Implantation of the HiRes90K™ Advantage Cochlear Implant With HiFocus™ Mid-Scala and Development of a Combined Electric and Acoustic Stimulation Technology in Adults With Partial Deafness

> **NCT02189798** · NA · TERMINATED · sponsor: **Advanced Bionics** · enrollment: 67 (actual)

## Conditions studied

- Hearing Loss
- Partial Deafness
- Hearing Disorders
- Ear Diseases
- Otorhinolaryngologic Diseases

## Interventions

- **DEVICE:** HiRes 90K™ Advantage implant with HiFocus™ Mid-Scala electrode
- **DEVICE:** EAS sound processor

## Key facts

- **NCT ID:** NCT02189798
- **Lead sponsor:** Advanced Bionics
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-10-21
- **Primary completion:** 2022-03-29
- **Final completion:** 2022-03-29
- **Target enrollment:** 67 (ACTUAL)
- **Why stopped:** Thirty-five subjects wore the EAS processor for as long as 84 months without significant safety issues. Sufficient data gained to support EAS technology development for safe use in subjects with residual low-frequency acoustic hearing sensitivity.
- **Last updated:** 2025-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02189798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02189798, "Implantation of the HiRes90K™ Advantage Cochlear Implant With HiFocus™ Mid-Scala and Development of a Combined Electric and Acoustic Stimulation Technology in Adults With Partial Deafness". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT02189798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*